HIV Life Cycle & Genetics

Similar documents
Human Immunodeficiency Virus

Fayth K. Yoshimura, Ph.D. September 7, of 7 HIV - BASIC PROPERTIES

Citation for published version (APA): Von Eije, K. J. (2009). RNAi based gene therapy for HIV-1, from bench to bedside

HIV Infection and Epidemiology: Can There Be a Cure? Dr. Nedwidek

Centers for Disease Control August 9, 2004

Lentiviruses: HIV-1 Pathogenesis

Going Nowhere Fast: Lentivirus genetic sequence evolution does not correlate with phenotypic evolution.

MID-TERM EXAMINATION

Micropathology Ltd. University of Warwick Science Park, Venture Centre, Sir William Lyons Road, Coventry CV4 7EZ

Retroviruses. ---The name retrovirus comes from the enzyme, reverse transcriptase.

Fayth K. Yoshimura, Ph.D. September 7, of 7 RETROVIRUSES. 2. HTLV-II causes hairy T-cell leukemia

11/15/2011. Outline. Structural Features and Characteristics. The Good the Bad and the Ugly. Viral Genomes. Structural Features and Characteristics

HOST-PATHOGEN CO-EVOLUTION THROUGH HIV-1 WHOLE GENOME ANALYSIS

HIV-1 Subtypes: An Overview. Anna Maria Geretti Royal Free Hospital

HIV/AIDS. Biology of HIV. Research Feature. Related Links. See Also

Under the Radar Screen: How Bugs Trick Our Immune Defenses

HIV INFECTION: An Overview

An Evolutionary Story about HIV

Emerging Diseases. Biosciences in the 21 st Century Dr. Amber Rice October 26, 2012

L I F E S C I E N C E S

19 Viruses BIOLOGY. Outline. Structural Features and Characteristics. The Good the Bad and the Ugly. Structural Features and Characteristics

Evolution of influenza

Viral Vectors In The Research Laboratory: Just How Safe Are They? Dawn P. Wooley, Ph.D., SM(NRM), RBP, CBSP

HIV-1 Dual Infection and Neurocognitive Impairment

LESSON 4.6 WORKBOOK. Designing an antiviral drug The challenge of HIV

VIROLOGY. Engineering Viral Genomes: Retrovirus Vectors

HIV & AIDS: Overview

Chapter 19: The Genetics of Viruses and Bacteria

Overview: Chapter 19 Viruses: A Borrowed Life

How HIV Causes Disease Prof. Bruce D. Walker

7.013 Spring 2005 Problem Set 7

Viral Genetics. BIT 220 Chapter 16

HIV-1 acute infection: evidence for selection?

INVESTIGATION OF VIRAL GENETIC AND BIOLOGIC DETERMINANTS OF HIV-1 SUBTYPE C PREDOMINANCE IN INDIA. Milka A. Rodriguez

Fig. 1: Schematic diagram of basic structure of HIV

Acquired immune deficiency syndrome.

Lecture 2: Virology. I. Background


MedChem 401~ Retroviridae. Retroviridae

2.1 VIRUSES. 2.1 Learning Goals

Coronaviruses. Virion. Genome. Genes and proteins. Viruses and hosts. Diseases. Distinctive characteristics

Running Head: AN UNDERSTANDING OF HIV- 1, SYMPTOMS, AND TREATMENTS. An Understanding of HIV- 1, Symptoms, and Treatments.

Irina Maljkovic Berry

Human Immunodeficiency Virus. Acquired Immune Deficiency Syndrome AIDS

Mayo Clinic HIV ecurriculum Series Essentials of HIV Medicine Module 2 HIV Virology

5. Over the last ten years, the proportion of HIV-infected persons who are women has: a. Increased b. Decreased c. Remained about the same 1

Chapter 13 Viruses, Viroids, and Prions. Biology 1009 Microbiology Johnson-Summer 2003

, virus identified as the causative agent and ELISA test produced which showed the extent of the epidemic

Lecture 11. Immunology and disease: parasite antigenic diversity

Sequence Analysis of Human Immunodeficiency Virus Type 1

Patricia Fitzgerald-Bocarsly

Chapter 08 Lecture Outline

Introduction retroposon

Ebola Virus. Emerging Diseases. Biosciences in the 21 st Century Dr. Amber Rice December 4, 2017

Medical Virology. Herpesviruses, Orthomyxoviruses, and Retro virus. - Herpesviruses Structure & Composition: Herpesviruses

Influenza viruses. Virion. Genome. Genes and proteins. Viruses and hosts. Diseases. Distinctive characteristics

A VACCINE FOR HIV BIOE 301 LECTURE 10 MITALI BANERJEE HAART

Section 6. Junaid Malek, M.D.

levels of genes were separated by their expression levels; 2,000 high, medium, and low

Development of Broadly Reactive HIV-1/AIDS Virus-like Particle Vaccines. Sean Patrick McBurney. B.S. Microbiology, University of Pittsburgh, 2004

MID 36. Cell. HIV Life Cycle. HIV Diagnosis and Pathogenesis. HIV-1 Virion HIV Entry. Life Cycle of HIV HIV Entry. Scott M. Hammer, M.D.

HIV-1 SUBTYPE C MOTHER-TO-CHILD TRANSMISSION: GENETIC AND IMMUNOLOGIC CORRELATES. Elizabeth Susan Russell

Chronic HIV-1 Infection Frequently Fails to Protect against Superinfection

AP Biology. Viral diseases Polio. Chapter 18. Smallpox. Influenza: 1918 epidemic. Emerging viruses. A sense of size

HIV Immunopathogenesis. Modeling the Immune System May 2, 2007

RAISON D ETRE OF THE IMMUNE SYSTEM:

Selection on the Human Immunodeficiency Virus Type 1 Proteome following Primary Infection

Are we targeting the right HIV determinants?

Received 19 May 2004/Accepted 13 September 2004

Virus and Prokaryotic Gene Regulation - 1

Retroviral RNA Processing and stability

Reverse transcription and integration

Prokaryotic Biology. VIRAL STDs, HIV-1 AND AIDS

Discovery of HIV and Early Findings

HIV and drug resistance Simon Collins UK-CAB 1 May 2009

Modeling and Simulation of HIV-1 Intracellular Replication

I. Bacteria II. Viruses including HIV. Domain Bacteria Characteristics. 5. Cell wall present in many species. 6. Reproduction by binary fission

VIRUSES AND CANCER Michael Lea

Characterizing intra-host influenza virus populations to predict emergence

A new wild-type in the era of transmitted drug resistance

Feb 11, Gene Therapy. Sam K.P. Kung Immunology Rm 417 Apotex Center

EVOLUTION. Reading. Research in my Lab. Who am I? The Unifying Concept in Biology. Professor Carol Lee. On your Notecards please write the following:

Ch 18 Infectious Diseases Affecting Cardiovascular and Lymphatic Systems

A PROJECT ON HIV INTRODUCED BY. Abdul Wahab Ali Gabeen Mahmoud Kamal Singer

Current Strategies in HIV-1 Vaccine Development Using Replication-Defective Adenovirus as a Case Study

Lecture 2 Evolution in action: the HIV virus

PATHOLOGY OF AIDS. Version 16. Edward C. Klatt, MD. Florida State University College of Medicine July 27, 2005

HIV acute infections and elite controllers- what can we learn?

University of Cape Town

AP Biology Reading Guide. Concept 19.1 A virus consists of a nucleic acid surrounded by a protein coat


Prevention of infection 2 : immunisation. How infection influences the host : viruses. Peter

Case Study. Dr Sarah Sasson Immunopathology Registrar. HIV, Immunology and Infectious Diseases Department and SydPath, St Vincent's Hospital.

RAISON D ETRE OF THE IMMUNE SYSTEM:

HIV-1 subtype C in Karonga District, Malawi. Simon Travers

Supplementary information. MARCH8 inhibits HIV-1 infection by reducing virion incorporation of envelope glycoproteins

GOVX-B11: A Clade B HIV Vaccine for the Developed World

Rama Nada. - Malik

cure research HIV & AIDS

Transcription:

HIV Life Cycle & enetics! etroviruses (and transposable elements) appear to be part of every cell's genome! From bacteria to yeast, flies, fish, and humans! ome endogenous retroviruses (most notably in mice and chickens) can be activated to replicate and induce tumors! The great majority of sequences in eukaryotic genomes that are related to retroviruses seem innocuous! Composition of the human genome:! % LT elements! % etrotransposons! 7% Human endogenous human retroviruses (HV)! HV-K! ~0 full-length proviruses (at least are intact)! 0-50 partial! ~000 solo LTs!.5% Unique coding sequences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

WHB&.$($0-#&"-&4")?("+0-!"#$%&'()*+,-.$/0*(& Overview of the HIV lifecycle The Impact of HIV enetics on the Fight gainst I is Broad Mo le c u la r pidemiology Therapy and rug esistance 5 Vaccine evelopment isease evelopment

N genome of a simple retrovirus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enome organization of the major retrovirus groups: N replication intermediates 5 7 9kb Open eading Frames (OF) employed to encode each protein *-&;*"$-7&Y("4*&;Y:&4"&0&WHBCZL vpr rev env pol gag v i f tat vpu tat nef 000 000 000 4000 5000 5 6000 6 7000 7 000 9000 9kb KLM>N>KO!<PHP rev :)!'$+6-)!5)./4+$&()(!-$)!*%6'5)7!-.!).*%)!-.!-(!=)!+.*%6'5))5=!&.)$(%%!-$$-=! %;!)7'$)((+%.!$)#&5-%$(!).*%)!?=!-&7+5+-$=!#).)(!;%&.!+.!)!*).$-5!"?)B)).!!"#! -.!$%&0!-.!T!"B++.!$%&!-.!?)B)).!$%&!-.!L0!$)#+%.(!%;!)!4+$-5!#).%6) :)()!#).)(!-$)!)7'$)(()!;$%6!-!()$+)(!%;!+U)$)./-55=!('5+*)!6HK( '('!-.!)$&!-$)!)!%.5=!)(()./-5!-&7+5+-$=!#).)( etrovirus genes are written in: lower case italics, etrovirus proteins are written in: first letter Upper case %&-6)74$&.-9&$%&'()*+,-.!#/'7")/-&%#$'/%++#/-$$)%#'*&#)0#&,%# /&'"-+7)/#/'$%##&,%#()$-""#%0/'%# $%(%$+%#&$-0+/$)&-+%#9:;<#-0#:=-+%># %0?7%+@# ;,%#+)0"%#+&$-0%#'+)4(%#+&$-0#()$-"# :=!#)+#/')%#&'#-#'*"%#+&$-0%#B=!# )0&%$7%)-&%@ ;,%#$%+*"40#")0%-$#+B=!#/'0&-)0+# &%$7)0-"#$%%-&+#'5#+%C*%0/%+#*0)C*%#&'# &,%##-0#F#%0+#'5#&,%#()$-"#:=!#9# -0#F#$%)'0+<#-0#$%%-&%#-&#'&,# %0+#'5#&,%#:=!#9:<@#;,%#$%+*"40# %"%7%0&+#-$%#/-""%#"'0#&%$7)0-"#$%%-&+# 9H;:<@ N N N N N N N Cellular tn N N N N N N,&7"

H-)*7("+0- H)0%-$#'*"%#+&$-0%#")0%-$# ()$-"#B=!#&$-(%"+#5$'7#&,%# /&'"-+7#&'#&,%#0*/"%*+I#.,%$%#)&#7-#%#/)$/*"-$)?%# 9-#%-#%0<#'$#)0&%$-&%# )0&'#/%""*"-$#B=!#&,$'*,#&,%# -/4'0#'5#&,%#()$-""#%0/'%# ":#$'&%)0@#;,%#&%$7)0-"## -+%#-)$+#9<#'5#()$-"#B=!# -$%#$%7'(%#-0#&,%#/%""*"-$# ).&5+,-.$4)&#-$%# *")/-&%#)0#&,)+#$'/%++@#;,%# $%+*"40#)0&%$-&%#+&$*/&*$%# )+#/-""%#-#'-6)74@# HIV replicates at an enormous rate: ~0 0 virions/day / life of virions in the blood ~h / life of most infected cells ~d ome infected cells harbor latent virus, with activation occurring slowly, potentially over many years HIV evolves ~ million times faster than the human genome: Transmission and the formation of an HIV quasispecies Transmission Purifying election Immediate descendents of one sequence predominates (usually) ~ll daughter viruses are genetically distinct ~ error is incorporated into every HIV genome Our most extensive sampling has been trivial: ~00 sequences/sample: ~/00 billionth of yearly output!"#$%$&'(%'$! efers to the entire collection, pool, or cloud of virus variants in the given setting referred to. The setting could be a tissue, a fluid compartment, a person, a collection of people or the entire earth s population of infected individuals. Citation for its use in HIV research (Meyerhans et al, Cell (9) 5:90), term s originator (M. igen, ci. mer., /9, 69:4-49)

Viral Population iversity (within sample variation) ivergence T= 5 T= 4 Founder strain T= T= Point mutations T= ecombination Founder $") %P&"!'#( #"* %P&"!!'( N -", %p/"!*( N 4!")) %P&"!!'( P +") %P&"!+( +"* %P&"!!'( *"# %P&"!!'( #"# %P&"!!'( $"* %P&"!!*(,"* %P&"!!+( N N P #", %P&"!!'( -". %P&"!!'( P P #") %P&"!!'( -"+ %N( Plasma Viral Load!"#$yr %P&"!!'( 7 6 5 4 0 volution of HIV env genes in the blood of a person over time % 0000 000 6000 4000 0 000 4 5 6 7 Years of ge C! Cells HIV explores New volutionary pace in ach Infection Herbeck (06) VI, 0:67 Pt. Pt.7 HIVU95460 Pt.6 Pt.9 HIVU596 Pt. Pt. HIVU64 Pt. Patient #6 from Wolinsky et al. HIVU607 HIVU605 HIVU590 0% HIV ecovers ncestral Features uring arly Infection Pt.5

HIV- env N roup Molecular M roup IVcpz / O roup B U Kaliningrad outbreak: F B/ I! Cross species transmission and the origins of human infections! escription and spread of the pandemic (65 million pidemiology Central China outbreak: B/C 0% infections, tens of thousands of partial genome sequences, a few thousand whole viral genomes) C H! pread of emerging epidemics! Transmission linkages IVcpz Clades "HIV ubtypes# within the HIV$% phylogenetic tree are becoming more obscure& Virus recombinants are becoming more evident and are signi'cant in emerging epidemics& lobal distribution of HIV subtypes HIV Types, roups and ubtypes There are two types of HIV: HIV- and HIV- Both types are transmitted by sexual contact, through blood, and from mother to child, and they appear to cause clinically indistinguishable I. HIV- is less easily transmitted, and the period between initial infection and illness is longer Worldwide, the predominant virus is HIV-, with HIV- type concentrated in West frica and rarely elsewhere Based on genetic similarities, the numerous virus strains may be classified into types, groups and subtypes. The strains of HIV- can be classified into three groups: the "major" group M, the "outlier" group O and the "new" group N. These three groups represent three separate introductions of simian immunodeficiency virus (from chimps..?) into humans. roup O appears to be restricted to west-central frica and group N - discovered in 99 in Cameroon - is extremely rare. Within group M there are known to be at least nine genetically distinct subtypes (or clades) of HIV-. These are subtypes, B, C,, (), F,, H, and K.

Intra ubtype iversity - % 6% 4% N Botswana Burundi India outh frica Tanzania Zimbabwe Botswana 7.%.7% 5.% 7.%.% 9.9% Burundi 5.% 5.9% 9.0% 7.7%.6% India 4 0.% 5.5% 6.% 7.% outh frica 55 7.% 9.% 9.6% Tanzania 9.0%.6% Zimbabwe 0.7% volution from genomic chimerization (recombination) % 0% % 6% vs India vs Other vs Botswana vs Burundi vs outh frica vs Tanzania vs Zimbabwe One person is infected from two sources 4% % 0% 0.0 0.0 0.05 0.07 0.09 0. 0. 0.5 0.7 0.9 0. 0. 0.5 0.7 0.9 More Two virions from different sources infect the same cell Nucleotide istance Chimera formation Fate of infecting strains Interpretation ach virion goes through reverse transcription, integration and produces viral N One of each N is packaged in a single virion The hybrid virion infects a new cell, reverse transcription occurs and T switches between templates, creating a chimeric proviral genome Lin Lin B Time Lineage extinction and replacement in nonoverlapping target cell populations. Coexistent independent lineages in non-overlapping target cell populations Formation of complex recombinant lineages in shared target cell populations

WHB&$#&"%+.")*&)'(0?7'&)'*& #"4*&40/*%?/"(&(*7?/")0(& #$7-"/#&)'")&"%+.")*&)'*&I>[& %*//&)0&(*#0-&)0&"-&$-*%+0- T (transactivator response region) N'*(*0(*@&0-%*&)'*& $44?-*&##)*4&$#&"%+.")*& )0&(0)*%)&)'*&*(#0-@&)'*&.$(?#&$#&"%+.")*&"-&P$//#& )'*&$44?-*&%*//# Transactivation by Tat 0 ev function Vif function Blocks synthesis and packaging into virions

Vpu effects Nef down-modulates several receptors from the surface of infected C4 + T cells to:.educe cytotoxic T lymphocyte (CTL) lysis,.suppress cell migration,.facilitate virus release and 4.modulate signal transduction by the immunological synapse Nef induces downstream signalling events to: 5.activate nuclear factor of activated T cells (NF-T), 6.nuclear factor-b (NF-B) and 7.activator protein (P), Nef induces efficient transcription of:.the viral long terminal repeat (LT) promoter, 9.inflammatory cytokines, 0.activation markers and.death receptors Nef effects Vpu targets C4 for degradation in the proteasome and counteracts tetherin (also known as BT), an interferon- (IFN)-induced host restriction factor, by an as-yetunknown mechanism. Consequently, Vpu facilitates virus release and the incorporation of functional gp0 into progeny virions =\"%'4*-)&"-&*-)(&0&WHB& 6)?$*#&0-&WHB&0.*(&)'*&"#)&]&*"(#&'".*&*/?%$")*&$)#&*-)(&(0%*##&)0&)'*& *7(**&)'")&$)&$#&)'*&5*#)&?-*(#)00&0&"-&'?4"-&.$(?#M&N'*&)0&.$("/& *-.*/0*&7/%0(0)*$-#@&7Z^_&"-&7[Z@&"(*&(*#0-#$5/*&0(&"\"%'4*-)&"-& 4*45("-*&?#$0-@&(*#*%+.*/M&N'*&%*//&#?("%*&7/%0(0)*$-&I>[&$#&?#*&"#& )'*&($4"(&(*%*)0(@&"-&0-*&0&"&*&0)'*(&(0)*$-#&"(*&?#*&"#&%0C (*%*)0(#&)$%"//&II;]&"-&I`I;[:M